Plain-English translation of NCT06788548 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new surgical approach called fluorescence-guided laparoscopic-endoscopic cooperative surgery for patients with early stomach cancer. The new approach combines two camera techniques—one passed through the mouth and one through small cuts in the abdomen—to help surgeons precisely identify and remove only the lymph nodes that are most likely to contain cancer, while preserving as much healthy stomach function as possible.
Current treatment for early stomach cancer either removes the entire stomach or doesn't remove enough tissue in some cases, potentially compromising quality of life. This trial exists to see whether this new targeted surgical approach can be both safe and effective, and whether it can help patients recover better and maintain better stomach function after surgery.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo the new surgical approach performed by trained surgeons at a participating hospital. Before surgery, you'll have imaging tests (CT scans) and possibly an endoscopy to map out your cancer. During the procedure, surgeons will use both a camera inserted through your mouth and cameras through small abdominal cuts to precisely remove your cancer and only the lymph nodes most likely to be affected. After surgery, the research team will track your recovery and assess how well your stomach is functioning through follow-up visits and tests.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China